Literature DB >> 8916088

Physiological levels of beta-amyloid peptide promote PC12 cell proliferation.

Y Luo1, T Sunderland, G S Roth, B Wolozin.   

Abstract

Alzheimer's beta-amyloid peptide (A beta) is normally present at a subnanomolar (225-625 pM) concentration in body fluids and in the medium of cultured cells. The potential actions of physiologic levels of A beta are being investigated. We have recently shown that nanomolar doses of A beta can stimulate tyrosine phosphorylation and activate phosphatidylinositol-3-kinase in neuronal cells. Here we show evidence that A beta at nanomolar levels promotes cell growth determined by [3H]thymidine incorporation, protein content and cell counts. Physiological levels of A beta peptides, including 1-40, 1-42, 25-35, all promote growth of PC12 cells in low serum medium with doubling times of 71 h to around 30 h. Although the promotion of cell proliferation can be detected at nanomolar levels of A beta, it's potency is less than that of serum. This suggests that A beta may normally play a neurotrophic/mitogenic role in neuronal biology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916088

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

Review 1.  Staying connected: synapses in Alzheimer disease.

Authors:  Hyoung-Gon Lee; Paula I Moreira; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

2.  Probucol suppresses enterocytic accumulation of amyloid-β induced by saturated fat and cholesterol feeding.

Authors:  Menuka M Pallebage-Gamarallage; Susan Galloway; Ryusuke Takechi; Satvinder Dhaliwal; John C L Mamo
Journal:  Lipids       Date:  2011-07-31       Impact factor: 1.880

Review 3.  Metals and amyloid-beta in Alzheimer's disease.

Authors:  Christa J Maynard; Ashley I Bush; Colin L Masters; Roberto Cappai; Qiao-Xin Li
Journal:  Int J Exp Pathol       Date:  2005-06       Impact factor: 1.925

4.  Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways.

Authors:  H K Jin; J S Bae; S Furuya; J E Carter
Journal:  Cell Prolif       Date:  2009-07-13       Impact factor: 6.831

Review 5.  Oxidative stress in Alzheimer's disease.

Authors:  Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

Review 6.  Environmental factors in the development and progression of late-onset Alzheimer's disease.

Authors:  Moses N Wainaina; Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

7.  Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.

Authors:  Akihiko Nunomura; Toshio Tamaoki; Koich Tanaka; Nobutaka Motohashi; Masao Nakamura; Takaaki Hayashi; Haruyasu Yamaguchi; Shun Shimohama; Hyoung-gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurobiol Dis       Date:  2009-12-23       Impact factor: 5.996

8.  Targeting therapy for homocysteic acid in the blood represents a potential recovery treatment for cognition in Alzheimer's disease patients.

Authors:  Tohru Hasegawa; Wataru Ukai
Journal:  Aging (Albany NY)       Date:  2016-09-14       Impact factor: 5.682

Review 9.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

Review 10.  Oxidative stress and the pathogenesis of Alzheimer's disease.

Authors:  Yan Zhao; Baolu Zhao
Journal:  Oxid Med Cell Longev       Date:  2013-07-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.